Open Access
EDITORIAL
Perspective. Digoxin for interstage single ventricle patients: What could possibly go wrong?
* Corresponding Author: George F. Van Hare, Professor of Pediatrics (Cardiology), Department of Pediatrics, Washington University School of Medicine, One Children's Place/Campus Box 8116 – NWT, St. Louis, MO. Email:
Congenital Heart Disease 2019, 14(3), 321-323. https://doi.org/10.1111/chd.12760
Abstract
This article has no abstract.Cite This Article

This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.